Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study (Q44419273)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2003
edit
Language Label Description Also known as
English
Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study
scientific article published in April 2003

    Statements

    Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study (English)
    0 references
    1 April 2003
    1260-1266

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit